Infant HIV Infection Ups Risk for Congenital CMV Infection

Share this content:
Infant HIV Infection Ups Risk for Congenital CMV Infection
Infant HIV Infection Ups Risk for Congenital CMV Infection

THURSDAY, Oct. 25, 2018 (HealthDay News) -- HIV-exposed infants have high rates of congenital cytomegalovirus (cCMV) infection, and in utero HIV infection seems to be a major risk factor for cCMV, according to a study published in the October issue of The Pediatric Infectious Disease Journal.

Kristina Adachi, M.D., from the David Geffen UCLA School of Medicine in Los Angeles, and colleagues determined cCMV and urinary CMV load in a cohort of infants born to HIV-infected women not receiving antiretrovirals during pregnancy. Qualitative and reflex quantitative real-time polymerase chain reaction were used to test for CMV DNA in neonatal urine obtained at birth.

With urine specimens available for 58.9 percent of 1,684 infants, the researchers found that 6.5 percent were CMV-positive, with a mean CMV load of 470,276 copies/ml. Eighteen percent of 89 HIV-infected infants had cCMV versus 4.9 percent of 858 HIV-exposed uninfected infants. cCMV was present in 23.2 and 9.1 percent of infants with in utero and intrapartum HIV infection, respectively. The rates of cCMV were fourfold higher (adjusted odds ratio, 4.4) and sixfold higher (adjusted odds ratio, 6) among HIV-infected infants and HIV in utero-infected infants, respectively, compared with HIV-exposed uninfected infants. Risk factors for primary cCMV included infant HIV infection, particularly in utero infection.

"CMV screening is an important component of a comprehensive evaluation needed for HIV-exposed infants, particularly among those born to women not on antiretrovirals during pregnancy," the authors write.

The study was supported in part by Boehringer Ingelheim Pharmaceuticals Inc. and GlaxoSmithKline on behalf of ViiV Healthcare.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA: Gout Drug Uloric Increases Risk of Death

FDA: Gout Drug Uloric Increases Risk of Death

Medication is associated with increased risk of heart-related death and death from all causes

Since Early 2000s, Overdose Death Rates Are Highest in U.S.

Since Early 2000s, Overdose Death Rates Are Highest ...

U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s

National Health Spending Set to Increase 5.5 Percent Annually

National Health Spending Set to Increase 5.5 Percent ...

Long-observed demographic and economic factors expected to drive growth in health spending

is free, fast, and customized just for you!




Already a member?

Sign In Now »